Aaron Gorovitz serves as Executive at NRX Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Aaron Gorovitz has executed 5 insider transactions totaling $11.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 30, 2023 involved purchasing 35,000 shares valued at $11.2K.
Aaron Gorovitz currently holds 105,000 shares of NRX Pharmaceuticals, Inc. (NRXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Gorovitz has been a net buyer of NRXP stock. They have purchased $11.2K and sold $0 worth of shares.
Aaron Gorovitz's most recent insider trade was on Aug 30, 2023, when they purchased 35,000 shares at $0.32 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 8,336 | $N/A | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 8,336 | $N/A | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 16,678 | $N/A | Discretionary |